Please first review the information for authors — abstract submission guidelines.
Precision health and diagnostics has revolutionized treatment regimens by replacing them with ones that are more effective, less toxic, and positively impact survival.
In efforts to improve the efficacy of diagnostic assays and therapeutic agents, precise molecular recognition of disease-specific markers remains a major hurdle. Achieving only ‘On-Target’ therapeutics will also require technologies beyond this one-size-fits all approach. Innovations in the development of instrumentation, imaging modalities, and spectroscopic techniques support and empower these approaches, enabling bias-free routes to achieve a holistic understanding and treatment of disease states with spatiotemporal precision. Point-of-use platforms seek to bring bioanalytical assays to the individual, thus enhancing the speed with which results are available to caregivers, to exert rapid changes in treatment regimens, to benefit their patients’ health and wellness. Seminal advances in the miniaturization of instrumentation has led to a growing range of smart, accurate, and low-powered, portable biomolecular diagnostics with the ultimate goal of rendering sensors capable of personalized bioassays supporting therapies targeted to the individual.
This session aims to highlight nanotechnology-enabled precision therapeutics/therapies or nanotechnology-based analytical platforms to guide treatment regimen, to benefit all populations.
|Back to Top ↑|
2023 Symposium Sessions
Tuesday June 20
|1:30||Innovations in Precision Health and Diagnostics for Health Wellness|
|4:00||Precision Health - Posters|
2023 Symposium Program
Tuesday June 20
|1:30||Innovations in Precision Health and Diagnostics for Health Wellness||TBA|
|Session chair: Prakash Nallathamby, Notre Dame University, US|
|NearWave Imager: The First Entirely Handheld Real-time Frequency-Domain Near-Infrared Spectroscopy Imaging System|
R. Stillwell, Nearwave, US
|Size-tunable Indocyanine Green Based Contrast Agent Platform for Different Photoacoustic Imaging Applications.|
S. Singh, G. Giammanco, D.J. Lawrence, J.L. Moran, P.V. Chtinis, R. Veneziano, George Mason University, US
|Using Geometric Unified Digital Biomarkers to Detect Neurological Diseases|
W. Gu, Dasion (Data-to-Decision) Corporation, US
|A Multimodal Approach To Prehabilitation, Rehabilitation and Mental Readiness with VR|
V. Somareddy, Neuro Rehab VR, US
|Detection and treatment of endometriosis using a novel nanomedicine platform|
Y. Park, A. Demessie, A. Luo, O.R. Taratula, A.S. Moses, P. Do, L. Campos, Y. Jahangiri, C.R. Wyatt, H.A. Albarqi, K. Farsad, O.D. Slayden, O. Taratula, Oregon State University, US
|Biomimetic, Antibiotic Free, Nanoparticles for Agent Agnostic Broad Spectrum Antimicrobial Action including ESKAPE Pathogens|
J. Hopf, J. Olesk, C. Evans, J. Ross, D. Donahue, V. Ploplis, F. Castellino, S. Lee, P.D. Nallathamby, University of Notre Dame, US
|Stem Cell Precision Medicine Human Brain Disease Models|
R. Anand, Neurxstem Inc, US
|4:00||Precision Health - Posters||Expo Hall AB|
|Harnessing Emerging Technologies to Deliver Ecologically Valid Precision Therapeutics |
R. Kalungam, F. Elshobokshy, University of the District of Columbia, US
|Machine Learning and Natural Language Processing Based Models for COPD Exacerbation Prediction|
N. Orangi-Fard, Georgia Gwinnett College, US
|A Landscape of Infectious Disease In Vitro Diagnostic Devices: From 2000 to Present|
E. Bradford, MRIGlobal, US
|Identifying Polyploid Cells in Tissue Images to Aid in Drug Development for Diffuse Large B-Cell Lymphoma|
C. Rouse, Southwest Research Institute, US
|Translation of Cellular-Resolution OCT Images to H&E-Like Stained Images via Generative Adversarial Network|
S.T. Tsai, C.H. Liu, S.L. Huang, National Taiwan University, TW
|Digital Twins in Patient Care using Knowledge Graph Ontologies and Liquid Neural Networks|
L. Nye, Massachusetts General Hospital, US
To receive announcements and news, please join our mailing list.